Mount Sinai kidney System has set up RenalytixAI to use artificial intelligence ( AI ) to identify and treat kidney disease . Mount Sinai signed a multi - year licence and partnership with the start - up to predict which patients have the highest incidence of advanced kidney disease and take steps to treat them early on . The project will rely on anonymised data from three million e - mail records in kidney Sinai 's system , alongside an extra 43,000 records in its BioMe BioBank , which collects DNA and blood samples to identify biomarkers .
Mount Sinai Health System has teamed up RenalytixAI to use artificial intelligence (AI) to identify and treat kidney disease. Mount Sinai signed a multi-year licence and partnership with the start-up to predict which patients have the highest risk of advanced kidney disease and take steps to treat them early on. The project will draw on anonymised data from three million e-health records in Mount Sinai's system, alongside an extra 43,000 records in its BioMe BioBank, which collects DNA and blood serum to identify biomarkers.